Well, I expect prices to do down, but I wouldnt expect Illumina to solely compete on price. A spokesperson for MGI Tech Co., which owns Complete Genomics, said MGI is pleased with verdict. The reversible terminator IP has not theyre currently using this IP to block the sale of some MGI instruments. This information helps us to understand how our visitors use our website. Generates statistical data on how the visitor uses the website. Back in November, a federal jury ruled that four of Illuminas five patents in the California case were valid, awarding it $8 million, according to a Law360 report. Please see our Privacy Policy. Gene sequence giant Illumina is weighing its next moves after a federal jury in Delaware found the San Diego company infringed on two patents from a rival genomics company and awarded $334 million in damages. Our Standards: The Thomson Reuters Trust Principles. Even with multiplexing sequencing cant yet approach this. Analysts say the bad news is prompting investors to question the company's strategy of buying Grail, which Illumina forecasts will generate an operating loss of $670mn in 2023 on revenues of. So if youd be interest in investing in (or codeveloping) such a platform, get in touch. Illumina invented its 2-channel technology before the BGI patents, and BGI was unable to make 2-channel chemistry work until it copied Illuminas technology, the spokesperson said in a statement. So I expect Illumina to maintain a quality advantage. The stock closed Friday up 7.4. Personal data may be processed (e.g. Statistics cookies collect information anonymously. You can give your consent to whole categories or display further information and select certain cookies. Scripts to download SARS-CoV-2 replacements, Sony CCD-V8AF Video Camera Recorder Viewfinder CRT Notes, Playing with a Handycam CCD-F340 Viewfinder CRT Notes, Thoughts on a new approach to viral testing, Quick script to download Uniprot info for proteins from Pfam trees (Newick tree format), Notes on fixing a broken Gentoo grub install, Notes on using a ILX511 Linear CCD, AD9225 ADC, ICE40HX8K and Nmigen, Thoughts on interviewing with YC as a science based startup, 2018 DNA Sequencing Raises and Acquisitions. REUTERS/Mike Blake. In 2010, Illumina filed a complaint in California against Complete Genomics, an MGI subsidiary, alleging that the company infringed on three of its DNA sequencing patents with the latter companys Complete Genomics Analysis Platform. In response, Complete Genomics asserted that Illumina had attempted to achieve monopoly power in genome sequencing technology.. Reuters, the news and media division of Thomson Reuters, is the worlds largest multimedia news provider, reaching billions of people worldwide every day. At the moment there doesnt seem to be any effective competition to Illumina. analyse how our Sites are used. For cost savings, you can change your plan at any time online in the Settings & Account section. The case centers on 2019 lawsuit filed by Complete Genomics a U.S. subsidiary of Chinese genomics company BGI Group. Back in November, a federal jury ruled that four of Illumina's five patents in the California case were valid, awarding it $8 million, according to a Law360 report. You may occasionally receive promotional content from the San Diego Union-Tribune. Hoffmann Eitle (Munich): Leo Polz. The jury, which started deliberating Thursday afternoon, also found that sequencers sold by BGIs Complete Genomics Inc. infringe two of three Illumina patents, but it said all three shouldnt have been issued in the first place, mooting any potential award, according to the verdict issued in the U.S. District Court for the District of Delaware. For specific trademark information, see www.illumina.com/company/legal.html. Simmons + Simmons LLP. Illumina Inc. owes BGI Group, the worlds largest maker of commercial genetic sequencers, $333.8 million after a federal jury in Delaware found Friday that some of its DNA sequencing systems infringe two patents related to technology that deduces each nucleotides identity from two signals. Saves the visitors preferences selected in the Cookie Box of Borlabs Cookie. The reversible terminator IP has not they're currently using this IP to block the sale of some MGI instruments. (This story corrects statement in paragraph 1 that Complete Genomics is a subsidiary of BGI Genomics to reflect that it is part of BGI Group). Photodiode Amplifier Board, Photobeaching on the Genome Analyzer, using a IMX178, Single Dye Experiments on a Genome Analyzer, Genome Analyzer Quantum GEM 532nm Laser and filters. hb```v eah`hje0sDt'j;:*:::$ np4p&~P%CH@| .Hibe`1Fq10f@$` !1 Except Illumina dont make much money that way. You may change or cancel your subscription or trial at any time online. Want more news? The latter represented Qiagen in one of the proceedings. We are using cookies to give you the best experience on our website. By Hannah Albarazi (November 19, 2021, 10:09 PM EST) -- A California federal jury heard testimony Friday from gene sequencing company Illumina's expert witness that 10 judges who previously upheld Illumina's patents behind its next-generation technology "got it right," one day after Chinese-owned DNA sequencing company Complete Genomics offered expert testimony that Illumina's patents are invalid as obvious. U.S. District Court for the Northern District of California, Access to case data within articles (numbers, filings, courts, nature of suit, and more. ), Create custom alerts for specific article and case topics and, I took a free trial but didn't get a verification email. You can find more information about the use of your data in our, You can revoke or adjust your selection at any time under. But I think whats really more interesting to me are approaches that reduce the COGS. He said the company is also pleased that the jury invalidated the cases three Illumina patents. In July 2019, Illumina filed counterclaims alleging certain models of the BGISEQ and MGISEQ genetic sequencing instruments infringe three Illumina patents. Change the plan you will roll onto at any time during your trial by visiting the Settings & Account section. But in May, a Delaware jury decided that Illumina owes Complete Genomics more than $333 million for infringing on two patents, court documents state. The patents cover Illumina's proprietary sequencing-by-synthesis chemistry. [1/2]A new office building housing genetic research company Illumina is shown in San Diego, California, U.S., May 30, 2018. Whats your favorite San Diego County beach? European patent attorney Philippa Griffin of Mathys & Squire appeared as a strawman in the appeal hearing. An attorney for Complete Genomics said the company was pleased with the award, which the judge could multiply based the jury's finding of willful infringement. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. BGI Group, a genome sequencing company based in China, on Monday escalated its global intellectual property fight with rival Illumina Inc by filing a U.S. patent case against the California-based . It also bars U.S. sales of StandardMPS products through Jan. 21, 2023. But in May, a Delaware jury decided that Illumina owes Complete Genomics more than $333 million for infringing on two patents, court documents state. Illumina was represented by Colm Murphy, London partner of US law firm Cooley. Illumina's '973 patent is expected to expire in 2023 and the '444 patent in 2024. So I imagine what theyll do is reduce pricing so that theyre competitive but not the cheapest option. Patents. 287(a) for the following products: Infrastructure The two patents cover technology fornext generation sequencing and were revoked due to formal errors. Content from video platforms and social media platforms is blocked by default. %PDF-1.5 % Some of them are essential, while others help us to improve this website and your experience. 7,541,444 (the '444 Patent) and U.S. Patent No. %%EOF Some of them are essential, while others help us to improve this website and your experience. Illumina, or (ii) any expiration date or the end of the shelf-life pre-printed on the consumable, but in either event, no later than 12 months from the date of shipment. The license is limited to Illumina's current technology used for massively parallel sequencing in . Interpretation, Certificates (CofC, CofA) and Master Lot Sheets, AmpliSeq for Illumina Cancer Hotspot Panel v2, AmpliSeq for Illumina Comprehensive Cancer Panel, Breast Cancer Target Identification with High-Throughput NGS, The Complex World of Pan-Cancer Biomarkers, Microbiome Studies Help Refine Drug Discovery, Identifying Multidrug-Resistant Tuberculosis Strains, Investigating the Mysterious World of Microbes, IDbyDNA Partnership on NGS Infectious Disease Solutions, Infinium iSelect Custom Genotyping BeadChips, 2020 Agricultural Greater Good Grant Winner, 2019 Agricultural Greater Good Grant Winner, Gene Target Identification & Pathway Analysis, TruSeq Methyl Capture EPIC Library Prep Kit, Genetic Contributions of Cognitive Control, Challenges and Potential of NGS in Oncology Testing, Partnerships Catalyze Patient Access to Genomic Testing, Patients with Challenging Cancers to Benefit from Sequencing, NIPT vs Traditional Aneuploidy Screening Methods, SNP Array Identifies Inherited Genetic Disorder Contributing to IVF Failures, NIPT Delivers Sigh of Relief to Expectant Mother, Education is Key to Noninvasive Prenatal Testing, Study Takes a Look at Fetal Chromosomal Abnormalities, Rare Disease Variants in Infants with Undiagnosed Disease, A Genetic Data Matchmaking Service for Researchers, Using NGS to Study Rare Undiagnosed Genetic Disease, Progress for Patients with Rare and Undiagnosed Genetic Diseases. The stock closed Friday up 7.4 percent at $233.56 on the Nasdaq exchange. Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.Youll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. N choose K, with T targets. Here you will find an overview of all cookies used. "," m.t`2L*] Xl2$cb8PQF = Accept all It helps push throughout, reduce error rates, and increase read length. Mathys & Squire (London): Philippa Griffin, Strawman cookies endstream endobj startxref In April, Illumina won an $8 million verdict against BGI from a jury in Northern California federal court, as well as a permanent injunction. Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks. 2020 preliminary results: Illumina said it finished last year with about $4.517 billion in revenue, up 39% from 2020, including about $1.19 billion in fourth-quarter revenue, up 25% over. Hotjar Ltd., Dragonara Business Centre, 5th Floor, Dragonara Road, Paceville St Julian's STJ 3141 Malta. And I suspect is why theyre shopping around for acquisitions. Simply log into Settings & Account and select "Cancel" on the right-hand side. 9,085,798; 9,783,847; 10,000,800 and related patents and patent applications. According to MGIs statement:The parties also agree to a three-year period of peace with respect to claims of U.S. patent infringement and violations of any antitrust or unfair competition laws of the United States, during which time they will not sue each other or respective customers in the United States or accrue liability for existing platforms.. Tripadvisor picks two for top 10 in U.S. Endlessly curious La Jolla architect Eugene Ray still learning, imagining and creating at 90, Electric cars: More consumers now want to buy them, survey says, Boeing CEO loses $7M bonus, keeps $22.5 million compensation, Fashion Valley is getting a resort-style makeover, Ukraine ally Kallas fights for reelection in Estonia vote, Global race to boost electric vehicle range in cold weather, Paid express lanes grow more popular in once-reluctant South, Louisiana Gov. ), Illumina Win Over BGI Upheld as Judge Blocks Gene Sequencers (2), Illumina, BGI Trim Patent Claims as Another Jury Trial Looms, BGI Asks For New Patent Trial After $8 Million Loss to Illumina, BGI Must Pay Illumina $8 Million in Gene-Sequencing Patent Spat, Complete Genomics Inc. v. Illumina Inc. (D. Previously, Illumina said that US Patent No. Illumina also said Friday in a filing with the U.S. Securities & Exchange Commission that it may have to pay interest and an ongoing royalty until the patents expire in 2029 if it loses on appeal. BGI countersuedmonths later. For the global patent community. It has the same estimated expiration as the first patent. One is estimated to expire in December 2025, another in January 2026the jury found BGIs products infringe those twoand a third in February 2026. Law360, San Francisco (November 30, 2021, 11:16 PM EST) -- A California federal jury determined Tuesday that four out of five of Illumina 's patents behind its next-generation genome-sequencing . Griffins clients include New England Biolabs and the Ecole Polytechnique Fdrale De Lausanne (EPFL). 7,541,444, titled "Modified nucleotides," and claim 1 of U.S. Patent No. 6 February 2023 If you do nothing, you will be auto-enrolled in our premium digital monthly subscription plan and retain complete access for $69 per month. Please see our Privacy Policy. Hardware (Instrument) Hardware will conform to Illumina's specifications for 12 months after shipment from Illumina. The trial began April 25 and featured competing allegations that each companys DNA sequencing systems infringe the others patents. The above analysis relies on the fact that the COGS of competitors is probably going to be similar to Illumina. The patents in that case expire in August 2022 and January 2023. The listed products and their use are the subject of US Patent Nos. We use cookies and other technologies on our website. The costs of this technology have fallen sharply in recent years. The listed products and their use are the subject of US Patent Nos. original cluster generation IP has expired (from Manteia) has expired. Privacy Policy You may also opt to downgrade to Standard Digital, a robust journalistic offering that fulfils many users needs. Great! Reach him at blake.brittain@thomsonreuters.com. The jury also ruled that three Illumina patents in the case were invalid. Illumina has won a patent infringement suit in the UK against defendant MGI over DNA sequencing technology. The purchase of this product from Illumina, Inc., its affiliates, or its authorized resellers and distributors conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product by the buyer (whether the buyer is an academic or for-profit entity). The purchase of this product does not convey a license under any claims in the foregoing patents or patent applications direct to producing the product. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Competitors in this market include the German company Qiagen and the Chinese manufacturer of genetic sequencers BGI Group, as well as MGI. organisation Well, for a start I expect it to put downward pressure on Illuminas consumable pricing. Marketing cookies are used by third-party advertisers or publishers to display personalized ads. Host: https://www.illumina.com | Hotjar is an user behavior analytic tool by Hotjar Ltd.. We use Hotjar to understand how users interact with our website. The European Patent Office has destroyed several patents belonging to Illumina, a US manufacturer of genetic engineering equipment. It uses mutant DNA polymerase enzymes in nucleic acid sequencing reactions, which is particularly important for sequencing-by-synthesis. Premium access for businesses and educational institutions. | Del., No. Are there mutations in SARS-CoV-2 CDC qPCR Primer Sites? Try our Advanced Search for more refined results. You have to know whats happening with clients, competitors, practice areas, and industries. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. I figured Id summarize my thoughts here. If you disable this cookie, we will not be able to save your preferences. Opponents included strawmen as well as Qiagen, a Germany-based provider of DNA sequencing technology. The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs. This website uses cookies so that we can provide you with the best user experience possible. David Bilsker, a lawyer from Quinn Emanuel Urquhart & Sullivan LLP who represented Complete Genomics, said the jurys findings shows the strength of Rade Drmanacs inventions. IP addresses), for example for personalized ads and content or ad and content measurement. A technician uses an Illumina Inc. DNA sequencing machine at the Li Ka Shing Institute of Health Sciences at the Chinese University of Hong Kong in Hong Kong, China, on June 20, 2017. Standard Digital includes access to a wealth of global news, analysis and expert opinion. Illumina, a publicly traded company based in San Diego with more than $3.2 billion in revenue in 2020, claimed that BGI and its subsidiaries willfully infringed five of its patents related to. If External Media cookies are accepted, access to those contents no longer requires manual consent. You can revoke or adjust your selection at any time under Settings. The BGI unit said Illuminas customers infringe the patent, which Bloomberg Law estimates will expire in January 2029, when they use certain systems in combination with its recommended sample preparation and sequencing kits. Receive the latest patent news direct to your inbox. Justia Patents Patents Assigned to Illumina Patents Assigned to Illumina LAMINATE FLUIDIC CIRCUIT FOR A FLUID CARTRIDGE Publication number: 20230048094 Abstract: An apparatus includes a fluid reservoir and a laminate fluidic circuit positioned above the fluid reservoir. These two patents appear to be the fundamental IP required to build an Illumina-style DNA sequencer. Subscribe to CPIs free daily newsletterfor more headlines and updates on antitrust developments around the world. Here you will find an overview of all cookies used. Save Each company sought a reasonable royalty for the alleged infringement of its patents by certain features of the accused products. Illumina has sought to stay ahead by expanding its portfolio of sequencers. Harrods chief shrugs off recession fears because rich get richer, FCA regulator blamed for Arms decision to shun London listing, Argentina diary: Come armed with $100 bills, There are no domestic equity investors: why companies are fleeing Londons stock market, Clutching Warrens letter, Im still positive on stocks, The Murdaugh trial: a southern gothic tale that gripped the nation, Humanity is sleepwalking into a neurotech disaster, Who to fire? Further strawmen were patent attorney Leo Polz and Christian Kilger. See here for a complete list of exchanges and delays. During your trial you will have complete digital access to FT.com with everything in both of our Standard Digital and Premium Digital packages. personalising content and ads, providing social media features and to Then theyll let other players take the low end of the market and try and keep the high end where margins are higher (and users are willing to pay for slightly better data quality). 7, 771,973, titled "modified nucleotides" will expire in August 2022. The companies have a history of heated courtroom clashes. My name is Nava Whiteford. At the very least MGI will be unblocked from selling instruments in the US. The listed products and their use are the subject of the following US Patent Nos. User-provided information. Cooley (London): Colm Murphy, For Qiagen and as a strawman 7,566,537 and 9,410,200. May 6 (Reuters) - A Delaware jury on Friday ordered Illumina Inc (ILMN.O) to pay more than $333 million to a U.S. unit of Chinese genomics company BGI Group after finding that Illumina's. (Reuters) - Illumina Inc and BGI Group's MGI Tech Co and Complete Genomics have settled U.S. litigation over their rival DNA-sequencing technology, the companies said Thursday. IP addresses), for example for personalized ads and content or ad and content measurement. Personal data may be processed (e.g. For Illumina We use cookies and other technologies on our website. We use cookies and other technologies on our website. The question is, in what way does that fundamentally change the market. If you are under 16 and wish to give consent to optional services, you must ask your legal guardians for permission. The Illumina In-Licensed Patents as of the Effective Date are set forth on Annex II, provided that on and after the Effective Date, the Patents set forth on Annex IV (in-licensed by Sequenom from CUHK) shall be deemed added to Annex II, and Annex IV shall be deemed to no longer include any Patents. CH Kilger (Berlin): Christian Kilger, Strawman All were invalidated in Fridays verdict. Illumina contends the verdict is not supported by the evidence presented at trial. But how else will they respond? You can find out more about which cookies we are using or switch them off in settings. New configurations will bring longer read capabilities with more output for immune repertoire, shotgun metagenomics and more, Discover novel trait and disease associations with optimized tag SNPs and functional exonic content at an attractive price, DRAGEN v4.0 release enables machine learning by default, providing increased accuracy out of the box, Our instrument performance service helps reduce unplanned downtime and minimize instrument requalification, Robust methylation profiling microarray with extensive coverage of CpG islands, genes, and enhancers, Two DRAGENs help Cardio-CARE slay one petabyte of data to better understand heart disease in Hamburg, Together, were finding answers to lifes biggest questions and broadening the positive impact of genomics around the world, Get instructions for using Illumina DRAGEN Bio-IT Platform v4.0, Enable comprehensive genomic profiling with accurate and comprehensive homologous recombination deficiency assessment, Save on the Ribo-Zero Plus Microbiome rRNA Depletion Kit, restrictions apply, A multi-species, low-cost, genome-wide genotyping platform to support molecular breeding in small grains, A comprehensive, easy-to-implement, and versatile genomic analysis tool set for translational researchers, The NovaSeq 6000Dx is our first IVD-compliant high-throughput sequencing instrument for the clinical lab. offers FT membership to read for free. In addition, although Complete Genomics may seek an injunction, we do not believe there is a reasonable basis for the court to grant one, said Illumina in the filing. Illumina Inc.owes BGI Group, the world's largest maker of commercial genetic sequencers, $333.8 million after a federal jury in Delaware found Friday that some of its DNA sequencing systems infringe two patents related to technology that deduces each nucleotide's identity from two signals. As part of the deal, each party will drop any challenges to the California and Delaware jury decisions, and Illumina gets a license to the family of patents that BGI asserted in Delaware. Thousands of warm hubs have sprouted across Britain as high energy bills fuel a cost-of-living crisis, The No. No one on our HOA board has been elected and they all remain on by default year after year. 258 0 obj <>stream df-mp Drries Frank-Molnia & Pohlman Patentanwlte Rechtsanwlte PartG mbB, filed apatent infringement counterclaim against Illumina, https://policies.google.com/privacy?hl=en, https://www.hotjar.com/legal/policies/privacy/, https://www.facebook.com/privacy/explanation, https://policies.google.com/privacy?hl=en&gl=en, https://wiki.osmfoundation.org/wiki/Privacy_Policy. Essential cookies enable basic functions and are necessary for the proper function of the website. The European Patent Office has destroyed several patents belonging to Illumina, a US manufacturer of genetic engineering equipment. And I suspect companies like Element are working on something similar. We do not anticipate that this decision will affect our ability to supply and service our customers.. The DNA sequencing patents are interesting for competitors such as MGI and the BGI Group, which are also in the midst of patent infringement claims. 5,964,443 and 6,437,109, European Patent No 0927258 and related patents and patent application licensed from the Wisconsin Alumni Research Foundation. The companies have been embroiled in a global legal battle over their respective sequencing technologies, with court cases in countries including Germany, Denmark, Switzerland, and Turkey. As always there are niches to play in (base modifications, long reads etc.) According to an exhibitfiled with the complaint, Illumina said a BioRxivpreprintposted Feb. 20 proved CoolMPS technology infringed the '973 patent. Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI Companies, MGI Tech Co. Ltd; Latvia MGI SIA; MGI International Sales Co., Ltd; and BGI Complete Genomics Hong Kong Co., Ltd. So if these new players provide effective competition (which they should as the technology is basically the same) I expect there to be general downward pressure on consumable pricing, and well see margins go down from 10x COGS. The jury's verdict follows the decision of Judge William Orrick, in the same case, to award Illumina summary judgment on claims of infringement by BGI's StandardMPS and CoolMPS products. Illumina is constantly conducting research and development, leading to new, modified, and/or improved technology and products. 0 On November 30, 2021, a jury in the patent infringement suits between Illumina, Inc. and BGI Genomics Co. in the U.S. District Court for the Northern District of California returned a verdict invalidating certain patent claims of Illumina's U.S. Patent No. Illumina MiSeq Dx Cystic Fibrosis Assays, TruSeq Stranded total RNA Sample Prep Kits, BaseSpace Cohort Analyzer Related Products, BaseSpace Variant Interpreter Related Products, BaseSpace Correlation Engine Related Products. Personal data may be processed (e.g. Illumina makes ~10x on consumables. In a later Delaware case, Complete Genomics accused Illumina of infringing on its own patents with two-channel sequencing systems, kits to prepare DNA fragments for sequencing and kits to immobilize, amplify and sequence fragments. This is the first time the UK patent courts have truly grappled with sufficiency at a lower instance. Some of them are essential, while others help us to improve this website and your experience. An Encoding And Correction Approach for DNA Data Storage, Using an SBS-like approach to selectively amplify, Reprogramming a ATTINY85 to use an external oscillator using the Arduino IDE, Nanopore DNA Sequencing Research Groups (August 2018), DNA Sequencing Companies (Updated May 2020), Inheco Control 96 + CPAC Ultraflat Notes (TEC/Peltier), Veeco/Bruker AFM (nanosope) head teardown pics, uMD1 ChipKIT 32 HP Interferometer Interface, Penrose Puzzle Lessons Learned from Rev 0, Embedding Electronics in Transparent Resin, Another iPhone MEMS Mic (different configuration+layers), Throwing the BME280 Combined Pressure/Humidity Sensor in a SEM, MXq Quad Core Android Thoughts (and console kernel messages), 11inch Celestron CPC Series Telescope Repair Initial Photos, A Brief Computational Analysis of Pen-Pineapple Apple-pen, esp32 USB Stick (esp32 + ch340g + buck conv + sd card), FG-100 Soldering Iron Tip Temperature Sensor, Fiddling with a cheap 5 port dumb switch to add VLANs/port mirroring, Marking intervals in gnuplot graph (with shading), awk print text between 2 identical markers in a file, A git pre-commit hook to do SVN style $Date$ substitution, Sony WPSD5 Surround Sound System repair Notes, Interfacing Hitachi HD44780 LCDs using I2C on an Arduino, Notes on Genias new paper nanopore SBS, Are you sure this isnt horse? Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. and other data for a number of reasons, such as keeping FT Sites reliable and secure, The Biden administration is close to tightening rules on some overseas investments by American companies, A Volkswagen Group-backed automotive company announced plans this week to open a $2 billion electric truck and SUV manufacturing plant just outside of Columbia, South Carolina, Oklahoma voters are deciding whether to legalize marijuana sales for those 21 and older.